Primary hyperparathyroidism.

Manuel Muñoz-Torres, Antonia García-Martín

Journal: Medicina clinica 2019;150(6):226-232

PMID: 28992983

Abstract

Primary hyperparathyroidism (PHPT) is a common endocrinological process, characterized by chronic elevation of serum concentrations of calcium and parathyroid hormone (PTH). Many years ago, the most frequent forms of clinical presentation were symptomatic renal or skeletal disease with moderate or severe hypercalcemia; however, currently, most patients have few symptoms and mild hypercalcemia. A new form of presentation called normocalcemic PHPT has also been described but clinical consequences are not well established. The biochemical profile of PHPT is characterized by hypercalcemia and high or inappropriately normal PTH concentrations. Parathyroidectomy is the only definitive cure. Medical treatment with the calcimimetic cinacalcet has been shown to normalize calcemia in a high percentage of cases.

Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Address: Unidad de Metabolismo Óseo, Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Campus de la Salud, Instituto de Investigación Biosanitaria de Granada, Granada, España; Departamento de Medicina, Universidad de Granada, Granada, España. Electronic address: [email protected].; Unidad de Metabolismo Óseo, Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Campus de la Salud, Instituto de Investigación Biosanitaria de Granada, Granada, España; Departamento de Medicina, Universidad de Granada, Granada, España.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.